Display # 5 10 15 20 25 30 50 100 All
1
Entest BioMedical Files Grant Application With the National Heart, Lung and Blood Institute for Development of the Company's ENT-576 Laser Device for Treatment of COPD
Wednesday, 30 December 2009
129
2
Entest BioMedical Enters into LOI with Advanced Light Devices to Develop Laser Platform for Stem Cell / Laser COPD Treatment
Thursday, 10 December 2009
261
3
Entest Biomedical Enters into Discussions with Laser Manufacturer to Develop Proprietary Photoceutical Device for COPD Treatment
Tuesday, 24 November 2009
255
4
Entest BioMedical Files 3rd Patent Application for COPD Stem Cell Treatment
Wednesday, 18 November 2009
330
5
Entest BioMedical, Inc. Discusses How Therapies in Development May Yield Lucrative Revenue Streams for the Company
Tuesday, 10 November 2009
225
6
Entest BioMedical, Inc. Sees Substantial Opportunities in Treatment of Chronic Obstructive Pulmonary Disease
Thursday, 05 November 2009
241
7
Entest BioMedical Files Patent Application for Selective Targeting of Stem Cells to Lung Using Photoceutical Devices
Wednesday, 04 November 2009
225
8
Entest BioMedical Signs LOI with Quantum Advisors to Coordinate Development of COPD Stem Cell Therapy
Tuesday, 03 November 2009
221
9
Bio-Matrix Scientific Group, Inc. to Aggressively Pursue Private and Public Grants to Fund Research for Development of Stem Cell Treatment of Chronic Obstructive Pulmonary Disease (COPD)
Wednesday, 14 October 2009
221
10
Bio-Matrix Scientific Group Inc. Updates Progress on the Company's New Opportunities in COPD, Tumor Banking and Cancer Treatment
Friday, 09 October 2009
225
11
Bio-Matrix Scientific Group's Subsidiary Applies for Phase II Grant from National Cancer Institute for the Development of Immuno-Therapeutic Cancer Vaccine
Wednesday, 07 October 2009
211
12
Bio-Matrix Scientific Group and Therinject LLC Begin Development of Tumor Banking Facility in Conjunction with Cancer Therapeutic Vaccine
Wednesday, 23 September 2009
217
13
Bio-Matrix Scientific Group Inc. Chairman Comments on New Opportunities for both the Company and Its Majority Owned Subsidiary Entest BioMedical Inc.
Tuesday, 01 September 2009
214
14
Bio-Matrix Scientific Group and Entest BioMedical Finalizes New Immuno-therapeutic Cancer Vaccine Joint Venture with Therinject
Wednesday, 26 August 2009
217
15
Bio-Matrix Scientific's Research Subsidiary, Entest BioMedical, Inc., Files Stem Cell Therapy Patent Application for Treatment of COPD
Wednesday, 19 August 2009
214
16
Bio-Matrix Scientific Group in Joint Venture with Therinject and Entest BioMedical for New Immuno-Therapeutic Cancer Vaccine
Thursday, 13 August 2009
208
17
Bio-Matrix Scientific Group & Entest BioMedical Submit Research Proposal to U.S. Army for Funding Adipose-Derived Stem Cells to Treat Traumatic Brain Injury
Monday, 04 May 2009
420
18
Bio-Matrix Scientific Group and Entest BioMedical Sign Contract With UCLA Researcher...
Wednesday, 29 April 2009
370
